Stifel Initiates Coverage On Third Harmonic Bio with Buy Rating, Announces Price Target of $23
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Alex Thompson has initiated coverage on Third Harmonic Bio (NASDAQ:THRD) with a Buy rating and set a price target of $23.
June 18, 2024 | 9:14 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stifel analyst Alex Thompson has initiated coverage on Third Harmonic Bio with a Buy rating and set a price target of $23.
The initiation of coverage with a Buy rating and a specific price target of $23 by a reputable analyst from Stifel is likely to positively impact the stock price of Third Harmonic Bio in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100